Stent

In patients with venous outflow obstruction, a self-expanding stent was associated with improvements in patency, quality of life and functional outcomes at 36 months, according to new data from the ABRE study.

Medtronic announced it received FDA approval for its provisional bifurcation stenting technique utilizing a single drug-eluting stent for non-left main bifurcation lesions.

In the U.S., the use of carotid artery stenting has never been as widespread as that of carotid endarterectomy, which is partly a function of the CMS coverage decision. That may be about to change.

Abbott announced it received FDA approval, CE mark approval in Europe, and Pharmaceuticals and Medical Devices Agency approval in Japan, and has launched new 4.5 mm and 5 mm stent sizes.

The FDA approved an expanded indication for a transcarotid stent system to include patients at standard risk for adverse events from carotid endarterectomy, according to a press release from Silk Road Medical.

The FDA approved the Thoraflex Hybrid Frozen Elephant Trunk device for commercial sale in the U.S. for treatment of adults with complex aortic arch disease, according to an industry press release.

Medication and exercise are more beneficial in preventing a second stroke in those with intracranial atherosclerosis compared with placement of a blood vessel stent, new guidance from the American Academy of Neurology stated.

Cordis announced the FDA has approved its self-expanding vascular stent designed for transradial peripheral procedures in the iliac and superficial femoral arteries.

On Feb. 1, the first-in-human implantation of a novel miniaturized stent for infants and small children that can be expanded as they grew was performed at Children’s Hospital Los Angeles.

A venous stent was associated with improvement in pain and patient comfort while achieving patency for approximately 80% of patients at 3 years, researchers reported at the International Symposium on Endovascular Therapy.